About Clinrova

Strategic Clinical Leadership for Investor-Ready Trials

Clinical operations strategy is the foundation early-stage biotech, device, and pharma companies need to run credible, investor-ready trials—and that’s exactly what we deliver.

At Clinrova, we help you build and execute risk-informed clinical strategies that align science, operations, and business goals. Whether you need fractional leadership, targeted task support, or ready-to-use templates, we offer flexible solutions that grow with your program.

We focus on sponsor-dependent risks—like team resourcing, vendor oversight, and trial infrastructure—and help shape trial designs that stand up to investor and regulatory scrutiny.

This isn’t just about getting a study started. It’s about building a clinical program that’s scalable, defensible, and ready for what comes next.

Let’s not just plan your trial. Let’s plan your next move.

About the Founder

  • Ashley Gantt

    FOUNDER + STRATEGIST

    I’ve spent the past 18 years in clinical research—leading studies across academic medical centers, sponsors, CROs, and startups in roles ranging from Clinical Research Coordinator to Director of Clinical Operations. I’ve led global trials, launched first-in-human studies, and prepared teams for INDs, NDAs, and IPOs.

    Now, through Clinrova, I help early-stage biotech, diagnostics, and life science companies build clinical operations strategies that are investor-ready.

    Therapeutic Area Experience Includes:
    Neurology • Respiratory • Ophthalmology • Rheumatology
    Adult, pediatric, and geriatric populations

    Credentials & Background

    MS in Clinical Research

    BS in Biochemistry

    Based in Atlanta, GA

REQUEST CV